Ads from one online seller, Willow, tout semaglutide pills, even for people who wear size 4
Imbruvica (ibrutinib) Disease area(s): Oncology/hematology Manufacturer(s): AbbVie/Johnson & Johnson 2024 Sales (USD): $6.39 billion Why it sold so well: In 2024, Johnson & Johnson saw a 7% decline in global revenues of Imbruvica, primarily due to decreased demand and lower market share in the US, as well as reduced collaboration revenues internationally
The STEP 1 extension showed 11.6 percentage points of weight regained within 52 weeks of stopping semaglutide
you're getting a compound with the exact amino-acid sequencing, free from the contaminants and fillers that plague lower-quality sources
Pros Highest bioavailability of all forms Direct action on injured or inflamed tissues Proven effectiveness in animal and veterinary studies Flexible dosing and stacking with other peptides (e.g., TB500) Cons Requires injections (daily or every other day) Must be mixed and stored properly (cold chain sensitive) Higher cost compared to capsules or oral sprays May require sterile technique and user experience Best For Athletes and bodybuilders recovering from joint, tendon, or muscle injuries Post-surgical healing and performance-focused rehab For full cycle and dosing strategies, refer to: BPC157 Cycle Guide Oral BPC157 (Liquid Solutions) Oral BPC157 in liquid form typically delivered as a sublingual dropper or liquid swallowed directly is marketed as a gut-targeted version of the peptide
That is a very different psychological proposition from a daily obligation, and it is a large part of why people settle into it more easily than they expect